GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome ...
1 day ago · The FDA on Tuesday required GSK and Pfizer to include warnings about Guillain-Barré syndrome risk in the labels for their respiratory syncytial virus vaccines.. The directive follows a post-marketing study by the regulator, which found that patients inoculated with GSK’s Arexvy and Pfizer’s Abrysvo are at greater risks of developing GBS, a rare neurological disorder characterized by ...
GSK, Pfizer RSV shots must warn about rare paralysis risk
1 day ago · Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. Photo by Beata Zawrzel/NurPhoto via Getty Images Rankings
FDA requires Pfizer, GSK to add warning on label of RSV shots
1 day ago · The ruling will affect GSK’s Arexvy and Pfizer’s Abrysvo, both of which were approved by the agency in May of 2023 for adults 60 years or older and realized booming sales in their first year ...
GSK and Pfizer's RSV vaccines to carry warnings of neurological ...
2 days ago · GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said ...
GSK, Pfizer RSV Shots to Warn About Rare Neurological Disorder
2 days ago · GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they may be tied to an increased risk of a rare neurological side effect that can lead to paralysis ...
GSK, Pfizer RSV Shots Must Warn About Rare Paralysis Risk - Mint
2 days ago · GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they may be tied to an increased risk of a rare neurological side effect that can lead to paralysis ...
FDA adds warning to RSV shots from GSK, Pfizer
2 days ago · GSK’s and Pfizer’s vaccines for respiratory syncytial virus must carry labels warning of a possible increased risk of a rare neurological disorder, the Food and Drug Administration said Tuesday. The FDA has not determined a causal link between the shots and the condition, called Guillain-Barré syndrome, or GBS.
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA
1 day ago · FDA updates safety labels for Pfizer's Abrysvo and GSK's Arexvy RSV vaccines, citing increased Guillain-Barré syndrome risk. Study estimates 7-9 excess GBS cases per million doses.
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline …
Aug 1, 2019 · Pfizer Inc. (NYSE: PFE) today announced the closing of its joint venture with GlaxoSmithKline plc (NYSE: GSK) to combine the parties’ respective consumer healthcare businesses to create the world’s largest over-the-counter (OTC) business with …
Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Oct 7, 2024 · Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus (RSV) vaccine.